Our #Fosstodon #Introduction:
Medical teams make hundreds of high-pressure decisions daily. #AMPEL helps making the right decisions.
Developed by the Leipzig University Hospital, this non-profit platform provides all you need for real-time monitoring to catch critical risks in #PatientCare.
By 2026, we are going #OpenSource, bringing #ForEvidence clinical decision support to university clinics with full MDR compliance.
#HealthInnovation #DigitalHealth #MedicalAI #PatientSafety #CDS #CDSS
When Recovery Care Fails: Surgeon's Surgery Was 'Successful', but Patient Died Hours Later
#PatientSafety #CosmicSurgery #MedicalAccountability #Healthcare #AusNews #AIGenerated
Drugs and medical devices have to be put through long periods of rigorous testing and multiple stages of trials before they can be used on patients in practice.
But not #genAI / #LLMs! Why not?! [1]
I posted an article a few months ago about how doctors are already using LLMs in their practice right now, without any testing or trials, just marketing hype and wishful thinking.
The LLM creates summaries of patient records so the doctor doesn't have to bother to look at the records themselves. Then the doctor records the visit with their smartphone and an LLM transcribes and summarizes it. So the doctor is neither reading nor writing the actual medical records.
I predicted that people are going to be seriously harmed or die from the resulting inaccuracies (slop) in medical records and doctors' lack of knowledge of patient histories. And we won't find out about it until after it's been happening for a while [2].
Today I've seen several posts #onHere about a similar situation in the social work field. The link ICYMI:
https://www.theguardian.com/education/2026/feb/11/ai-tools-potentially-harmful-errors-social-work
The sad thing is the use of properly developed actual AI (what "AI" meant before the tech broligarchs came along and appropriated the term for their text generators) can do great things like detect cancer in medical scans, find useful new drugs, etc.
-----
[1] you guessed it: 'profit'
[2] no room to go into all the reasons here, just think about it
HYWEL DDA: Health board pays out after patient left with ‘significant sight impairment’ following ‘serious failings’
A damning report from the Public Services Ombudsman for Wales found the health board missed multiple opportunities to treat the patient, known as Mrs B, who was “lost to follow-up” for seven years.
The investigation found that clinicians failed to act on advice from another health board in 2012, did not carry out appropriate tests, and cancelled 11 appointments while the patient’s condition worsened.
The Ombudsman’s report concluded that if Mrs B had received appropriate care, she would likely have “retained useful vision in her right eye.”
Instead, the “devastating impact” has resulted in her losing her confidence and independence, becoming depressed and isolated, and now requiring care to live at home.
The health board has been ordered to pay Mrs B £4,500 for the “serious failings” and a further £300 for the time and trouble she was put to in pursuing her complaint.
Sharon Daniel, Director of Nursing, Quality and Patient Experience at Hywel Dda University Health Board, offered an unreserved apology.
“We acknowledge the findings of the Ombudsman’s report and we are sorry for the failings identified and the impact on the patient who was under our care and her family,” she said.
“We recognise that there were significant failures in the way we approached the treatment of our patient that led to her suffering significant sight impairment. We apologise unreservedly for these failures.
“This is not the level of service we wish to provide our patients and we will strive to do better.”
The Ombudsman’s investigation highlighted that even during the COVID-19 pandemic, no assessment was made of the risk to Mrs B’s sight, despite guidance stating that imminently sight-threatening conditions “MUST CONTINUE” to be treated.
The report also criticised an “inadequate” review in March 2022, where relevant tests were not done and an opportunity was missed to make an earlier referral for specialist treatment.
Ms Daniel confirmed the health board accepted the Ombudsman’s recommendations and had started to implement improvements.
These include increased staffing levels, a new glaucoma co-ordinator role, and a better system for categorising patients based on their risk of vision loss.
The health board is also installing a new electronic patient record system, ‘Open Eyes’, to improve record keeping and ensure seamless information sharing with neighbouring health boards like Swansea Bay University Health Board.
Related stories from Swansea Bay News
Llanelli teen invited to Parliament after years of agony from invisible illness
A young woman’s long fight for answers finally reaches Westminster.
Hendy BAFTA winner calls for Tourette’s understanding after BBC apology
A powerful plea for respect after a broadcast sparks outrage.
Swansea favourite Kev Johns recovering after minor stroke
Much‑loved entertainer thanks supporters as he begins his recovery.
Carmarthenshire mum says Guide Dogs support was a lifeline
A family shares how early help transformed life after their baby’s diagnosis.
More health stories
The latest updates on health, care and wellbeing across our region.
This brief highlights a critical epidemiological finding that bears on risk assessment and decision-making in clinical care. The reported association between risperidone use and increased stroke risk in dementia patients invites attention to how pharmacological choices intersect with geriatric safety, particularly when caution is warranted for individuals without prior vascular disease.
The emphasis on a large, population-based sample strengthens the relevance for practitioners involved in risk stratification, patient monitoring, and collaborative care planning across disciplines—psycho-social clinicians, social workers, and allied mental health professionals alike.
Article Title: 165,000 dementia patients reveal hidden stroke risk from common drug
Link to Science Daily Mind-Brain News: https://www dot sciencedaily dot com/releases/2026/03/260307213244 dot htm
via Mind & Brain News -- ScienceDaily https://www dot sciencedaily dot com/news/mind_brain/
March 8, 2026 at 04:45PM
#dementia #risperidone #stroke Risk #geriatricpsychiatry #patientSafety
Copy and paste broken link above into your browser and replace "dot" with "." for link to work.
We have to do it this way to avoid display of copyrighted images.
Utah's AI Prescription Trial Faces Critical Security Flaws
Ibogaine can be a powerful tool for addiction recovery — but safety protocols are non-negotiable. We've published a comprehensive guide covering cardiac screening requirements, medical contraindications, drug interactions, and red flags to watch for when choosing a treatment provider. Share with anyone considering this path.
Ibogaine can be a powerful tool for addiction recovery — but safety protocols are non-negotiable. We've published a comprehensive guide covering cardiac screening requirements, medical contraindications, drug interactions, and red flags to watch for when choosing a treatment provider. Share with anyone considering this path.
Ibogaine can be a powerful tool for addiction recovery — but safety protocols are non-negotiable. We've published a comprehensive guide covering cardiac screening requirements, medical contraindications, drug interactions, and red flags to watch for when choosing a treatment provider. Share with anyone considering this path.
Ibogaine can be a powerful tool for addiction recovery — but safety protocols are non-negotiable. We've published a comprehensive guide covering cardiac screening requirements, medical contraindications, drug interactions, and red flags to watch for when choosing a treatment provider. Share with anyone considering this path.
AMPEL Platform
The Daily Perspective
Lea
Editor
Psychotherapy Commission ACPE
ibogainetreatmentguide